Your browser doesn't support javascript.
loading
Gay and Bisexual Men's Perceptions about a Potential HIV Vaccine within a Post-COVID-19 Era: A Qualitative Study.
D'Angelo, Alexa B; Dearolf, Michelle H; MacMartin, Jennifer; Elder, Mathew; Nash, Denis; Golub, Sarit A; Grov, Christian.
Afiliação
  • D'Angelo AB; Department of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
  • Dearolf MH; CUNY Institute for Implementation Science in Population Health (ISPH), New York, NY, USA.
  • MacMartin J; Department of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
  • Elder M; CUNY Institute for Implementation Science in Population Health (ISPH), New York, NY, USA.
  • Nash D; Department of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
  • Golub SA; Department of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
  • Grov C; CUNY Institute for Implementation Science in Population Health (ISPH), New York, NY, USA.
AIDS Behav ; 2024 Aug 10.
Article em En | MEDLINE | ID: mdl-39122906
ABSTRACT
To end the HIV epidemic, there is need for targeted strategies to reduce HIV incidence for those most vulnerable, including an HIV vaccine. This study seeks to understand the perceptions that non-PrEP using gay and bisexual men and other men who have sex with men (GBMSM) have about a potential HIV vaccine, while contextualizing their perspectives within the context of heightened vaccine hesitancy that has emerged since the COVID-19 pandemic. Between March and May of 2022, GBMSM (N = 20) participated in in-depth interviews, which assessed their perceptions about an HIV vaccine. Interviews were analysed using a codebook approach to thematic analysis. We oversampled for those unvaccinated against COVID-19 as a proxy for vaccine hesitation. Participants expressed a range of enthusiastic support, cautious optimism and skepticism when presented with the possibility of an HIV vaccine. Factors that drove willingness to receive an HIV vaccine included community-oriented altruism, individualized risk-benefit assessment, and/or the perception that a vaccine could provide a beneficial shift in sexual experiences. Participants also expressed hesitations about receiving an HIV vaccine, including concerns about potential side-effects and efficacy, as well as mistrust in the vaccine development process. Notably, participants often evaluated the vaccine in comparison to PrEP and condoms. Participants offered specific insights into information they would like to receive about an HIV and where/how they would like to receive it. Our findings can help inform future HIV vaccine implementation efforts by offering insights into the factors that motivate and deter GBMSM to receive an HIV vaccine.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article